NuVasive patented a system for neurophysiologic assessments during spinal surgeries. The method involves transcutaneous stimulation of spinal nerves, monitoring neuromuscular responses, and adjusting surgical procedures based on nerve health changes. The patent aims to improve surgical outcomes and patient safety during spinal procedures. GlobalData’s report on NuVasive gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights NuVasive Inc - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on NuVasive, Surgical robots was a key innovation area identified from patents. NuVasive's grant share as of January 2024 was 57%. Grant share is based on the ratio of number of grants to total number of patents.

Monitoring nerve health during spinal surgery using neurophysiologic assessments

Source: United States Patent and Trademark Office (USPTO). Credit: NuVasive Inc

A recently granted patent (Publication Number: US11877860B2) outlines a method for neurophysiologic assessment during spinal surgical procedures. The method involves adhering electrodes to the patient's skin at specific locations, delivering transcutaneous, transabdominal stimulation signals to lumbar motor neural pathways, and monitoring neuromuscular responses to determine nerve health. By establishing an operative corridor to the surgical target site along a lateral, trans-psoas path, changes in nerve health can be detected by analyzing stimulation threshold intensities. The patent also describes a control unit that can toggle between alert testing and threshold testing modes to automatically evaluate nerve responses and display results indicative of nerve health during the procedure.

Furthermore, the patent includes instructions for a non-transitory computer-readable medium that provides graphical information on electrode placement and stimulation signals during the surgical procedure. The medium allows for the delivery of multiple transcutaneous, trans-abdominal stimulation signals, establishing baseline responses for muscles, and automatically evaluating responses to determine nerve health status. The method also includes features such as reminder alerts for nerve root tests, color indicators for alerts, and the ability to provide warnings based on predetermined thresholds. Overall, the patented method aims to enhance neurophysiologic assessment during spinal surgeries by utilizing advanced monitoring systems and control units to ensure the safety and health of the patient's nerves throughout the procedure.

To know more about GlobalData’s detailed insights on NuVasive, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.